Compare TOWA Hi SYSTEM Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -1.89% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of -0.39% and Operating profit at -1.89% over the last 5 years
3
Flat results in Mar 26
4
With ROE of 11.05%, it has a very attractive valuation with a 1.10 Price to Book Value
5
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,895 Million (Micro Cap)
10.00
NA
0.00%
-0.40
11.05%
1.12
Revenue and Profits:
Net Sales:
647 Million
(Quarterly Results - Mar 2026)
Net Profit:
145 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.66%
0%
-4.66%
6 Months
-7.28%
0%
-7.28%
1 Year
-6.11%
0%
-6.11%
2 Years
48.67%
0%
48.67%
3 Years
22.26%
0%
22.26%
4 Years
8.89%
0%
8.89%
5 Years
-36.56%
0%
-36.56%
TOWA Hi SYSTEM Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.39%
EBIT Growth (5y)
-1.89%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.54
Tax Ratio
32.40%
Dividend Payout Ratio
46.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.23%
ROE (avg)
9.43%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.10
EV to EBIT
5.18
EV to EBITDA
4.43
EV to Capital Employed
1.16
EV to Sales
1.24
PEG Ratio
0.60
Dividend Yield
NA
ROCE (Latest)
22.47%
ROE (Latest)
11.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
646.80
632.40
2.28%
Operating Profit (PBDIT) excl Other Income
217.20
213.90
1.54%
Interest
0.00
0.00
Exceptional Items
-37.30
0.00
Consolidate Net Profit
145.10
136.10
6.61%
Operating Profit Margin (Excl OI)
296.40%
297.20%
-0.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.28% vs -3.01% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 6.61% vs 26.72% in Dec 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
2,406.90
2,114.10
13.85%
Operating Profit (PBDIT) excl Other Income
638.00
500.80
27.40%
Interest
0.00
0.00
Exceptional Items
-7.40
0.00
Consolidate Net Profit
448.10
401.80
11.52%
Operating Profit Margin (Excl OI)
228.30%
199.70%
2.86%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 13.85% vs 3.55% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is 11.52% vs 55.44% in Sep 2024
About TOWA Hi SYSTEM Co., Ltd. 
TOWA Hi SYSTEM Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






